TABLE 4.
Patient characteristics according to TEACHH model prognostic group
| Characteristic | Group A (n = 10) | Group B (n = 387) | Group C (n = 108) |
|---|---|---|---|
| Type of primary tumor | |||
| Breast or Prostate | 4 (40.0%) | 73 (18.9%) | 10 (9.3%) |
| Lung or Other | 6 (60.0%) | 314 (81.1%) | 98 (90.7%) |
| ECOG performance status | |||
| 0‐1 | 10 (100.0%) | 239 (61.8%) | 15 (13.9%) |
| 2‐4 | 0 (0.0%) | 148 (38.2%) | 93 (86.1%) |
| Age (y) | |||
| ≤60 | 8 (80.0%) | 115 (29.7%) | 6 (5.6%) |
| >60 | 2 (20.0%) | 272 (70.3%) | 102 (94.4%) |
| Prior lines of palliative chemotherapy | |||
| ≤2 | 9 (90.0%) | 182 (47.0%) | 25 (23.1%) |
| >2 | 1 (10.0%) | 205 (53.0%) | 83 (76.9%) |
| Hepatic metastases | |||
| Absent | 10 (100.0%) | 277 (71.6%) | 29 (26.9%) |
| Present | 0 (0.0%) | 110 (28.4%) | 79 (73.1%) |
| Hospitalization in prior 3 mo | |||
| No | 10 (100.0%) | 161 (41.6%) | 8 (7.4%) |
| Yes | 0 (0.0%) | 226 (58.4%) | 100 (92.6%) |
| Time of death (d) | |||
| Within 0‐30 | 2 (20.0%) | 130 (33.6%) | 61 (56.5%) |
| Within 31‐60 | 5 (50.0%) | 21 (5.4%) | 2 (1.9%) |
| Within 61‐90 | 3 (30.0%) | 236 (61.0%) | 45 (41.7%) |
Abbreviation: ECOG, Eastern Cooperative Oncology Group.